European Union funds SK-IIDT-Vaxxas consortium for high-density microarray patch vaccines to enhance seasonal & pandemic flu protection.
Consortium comprising SK, IDT, and Vaxxas introduced a high-density microarray patch (HD-MAP) for vaccines in Europe, aiming to enhance vaccine efficacy and availability. They are focused on developing HD-MAP vaccines with high immunogenicity for both seasonal and pandemic influenza. The initiative is set to address pressing immunization challenges by capitalizing on innovative technology.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments